S0 CALPOL Tablets. Each tablet contains 500 mg Paracetamol. Reg no: 44/2.7/0321.

GlaxoSmithKline Consumer Healthcare South Africa (Pty) Ltd. 39 Hawkins Avenue, Epping Industria 1, Cape Town, 7460. Reg. No: 2014/173930/07. For full prescribing information refer to the professional information approved by the medicines regulatory authority. Always read the label prior/before to use. For any further information, including safety, adverse reactions, please contact the GSK Hotline on 0800 007 018, mystory.za@haleon.com. Trademarks are owned by or licensed to Haleon group of companies.

The PAIA manual is prepared in accordance with section 51 of the Promotion of Access to Information Act (PAIA) No. 2 of 2000 (as amended) and the Protection of Personal Information Act, 2013. The purpose of PAIA is to promote the right of access to information, to foster a culture of transparency and accountability within the Company by giving the right to information that is required for the exercise or protection of any right and to actively promote a society in which the people of South Africa have effective access to information to enable them to exercise and protect their rights.

Calpol Tablets contains Paracetamol. ALWAYS READ THE LABEL. Use only as directed. For the temporary relief of pain and fever. Incorrect use could be harmful. Consult your healthcare professional if symptoms persist.

The information on this site is intended for visitors from South Africa only. ©2020 Haleon Group of companies or its licensor.

1. This product contains paracetamol; do not take it with other medicines that also contain paracetamol. Paracetamol is contained in many medicines to treat pain, fever, symptoms of cold and flu, and sleep medicines.
2. If you have liver or kidney disease, talk to your doctor before taking paracetamol.
3. Do not take more than recommended dose, as this may be harmful, including serious harm to your liver.

Promotion Number: PM-ZA-CALP-22-00053